LUMNESILPA

Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunological diseases, namely autoimmune diseases, immune deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti inflammatories; pharmaceutical preparations for the prevention and treatment of respiratory system disorders; pharmaceutical preparations for the prevention and treatment of musculoskeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, pelvic inflammatory diseases; pharmaceutical preparations used in dermatology, namely dermatitis, diseases affecting skin pigmentation, sexually transmitted diseases; pharmaceutical preparations used in oncology; pharmaceutical preparations used in haematology, namely for the treatment of blood disorders; pharmaceutical preparations used for tissue and organ transplantation; pharmaceutical preparations used in ophthalmology; pharmaceutical preparations used in gastroenterology; pharmaceutical preparations for the prevention and treatment of eye disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals.